Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026)

Bausch Health Companies has disclosed Interest & Investment Income across 18 years of filings, most recently posting $10.0 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $10.0 million, down 9.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.0 million (up 34.29% YoY), and the FY2025 annual result was $48.0 million, up 45.45% from the prior year.
• Interest & Investment Income came in at $10.0 million for Q1 2026 at Bausch Health Companies, up from $9.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $15.0 million in Q3 2025 to a low of $2.0 million in Q1 2022.
• The 5-year median for Interest & Investment Income is $7.0 million (2023), against an average of $7.7 million.
• Across the five-year window, Interest & Investment Income soared 500.0% in 2022 and decreased 9.09% in 2026, its largest moves.
• Bausch Health Companies' Interest & Investment Income stood at $6.0 million in 2022, then grew by 16.67% to $7.0 million in 2023, then increased by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025, then grew by 11.11% to $10.0 million in 2026.
• The last three Interest & Investment Income figures came in at $10.0 million (Q1 2026), $9.0 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.